Chst15-IN-1|cas:2158198-77-5|西域试剂

Chst15-IN-1,98.09%

产品编号：Bellancom-124704| CAS NO：2158198-77-5| 分子式：C₁₇H₁₁BrCl₂N₂O₃| 分子量：442.09

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，

货号	价格	库存与货期
Bellancom-124704	￥1200.00	杭州北京（现货）
Bellancom-124704	￥1900.00	杭州北京（现货）
Bellancom-124704	￥3800.00	杭州北京（现货）
Bellancom-124704	￥6200.00	杭州北京（现货）
Bellancom-124704	￥9800.00	杭州北京（现货）

增值税发票√顺丰快递√订货电话：18601927057

Chst15-IN-1

产品介绍

Chst15-IN-1 是一种有效的可逆共价 Chst15 抑制剂。Chst15-IN-1 有效抑制 chondroitin sulfate-E (CS-E) 硫酸盐化水平和其他密切相关的 glycosaminoglycans (GAG) sulfotransferases。Chst15-IN-1 作为一种选择性sulfotransferase 抑制剂可以降低 chondroitin sulfate proteoglycans (CSPGs) 的抑制作用，并有希望用于刺激神经元修复。

生物活性

Chst15-IN-1 is a potent reversible covalent Chst15 inhibitor. Chst15-IN-1 effectively inhibits chondroitin sulfate-E (CS-E) sulfation levels and other closely related glycosaminoglycans (GAG) sulfotransferases. Chst15-IN-1, as a selective sulfotransferase inhibitor, can diminish the inhibitory effects of chondroitin sulfate proteoglycans (CSPGs), and can be used for the stimulation of neuronal repair.

体外研究

Chst15-IN-1 (25 μM; 24 hours; Neu7 astrocytes) is selective for sulfotransferases over the myriad of reactive cysteine-containing proteins. Chst15-IN-1 (10 and 25 μM; Neu7 astrocytes) shows a significant dose dependent decrease in cell-surface CS-E expression.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

Chst15-IN-1 (3.0 mg/kg; i.v.) has a moderate clearance of 21 mL/min/kg, moderate volume of distribution of 0.97 L/kg, and short terminal half-life of 1.6 hours.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Rats
Dosage:	3.0 mg/kg (Pharmacokinetic Analysis)
Administration:	I.v.
Result:	Had a moderate clearance of 21 mL/min/kg, moderate volume of distribution of 0.97 L/kg, and short terminal half-life of 1.6 h.

体内研究

Chst15-IN-1 (3.0 mg/kg; i.v.) has a moderate clearance of 21 mL/min/kg, moderate volume of distribution of 0.97 L/kg, and short terminal half-life of 1.6 hours.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Rats
Dosage:	3.0 mg/kg (Pharmacokinetic Analysis)
Administration:	I.v.
Result:	Had a moderate clearance of 21 mL/min/kg, moderate volume of distribution of 0.97 L/kg, and short terminal half-life of 1.6 h.

性状

Solid

溶解性数据

In Vitro:

DMSO : 50 mg/mL (113.10 mM; ultrasonic and warming and heat to 60°C)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	2.2620 mL	11.3099 mL	22.6198 mL
5 mM	0.4524 mL	2.2620 mL	4.5240 mL
10 mM	0.2262 mL	1.1310 mL	2.2620 mL

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式